ADXN
Addex Therapeutics
ADXN
ADXN
5 hedge funds and large institutions have $6.17M invested in Addex Therapeutics in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$3.87M |
| 2 |
UBS Group
Zurich,
Switzerland
|
$109K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $3.87M | +$3.87M | +30,762 | New |
|
|
CC
2
Caxton Corporation
Princeton,
New Jersey
| $1.67M | – | – | – |
|
|
NLVP
3
New Leaf Venture Partners
New York
| $315K | – | – | – |
|
|
NMC
4
NEA Management Company
Timonium,
Maryland
| $205K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $109K | +$27.1K | +215 | +33% |
|